{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:06:01Z","timestamp":1768874761868,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00261-019-02006-2","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T07:02:56Z","timestamp":1554706976000},"page":"2545-2556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["68Ga-PSMA-11 PET\/CT in newly diagnosed prostate cancer: diagnostic sensitivity and interobserver agreement"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9075-8020","authenticated-orcid":false,"given":"Mohammad Abd Alkhalik","family":"Basha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maged Abdel Galil","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"El-Diasty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser Ibrahim","family":"Abdelkhalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehia Omar","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Fathy","family":"Alasamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba A. E.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia Salah El","family":"Deen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Engy Fathy","family":"Tantawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha Ibrahim","family":"Metwally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed M. A.","family":"Zaitoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh Abdelaziz","family":"Aly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jehan Ibrahim","family":"Altohamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abd El Motaleb","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira Hamed Mohamed","family":"Afifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Harb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"2006_CR1","doi-asserted-by":"crossref","unstructured":"Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA: A Cancer Journal for Clinicians 2011; 61: 69\u201390.","DOI":"10.3322\/caac.20107"},{"key":"2006_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11934-016-0575-5","volume":"17","author":"L Lindenberg","year":"2016","unstructured":"Lindenberg L, Choyke P, Dahut W. Prostate cancer imaging with novel PET tracers. Current urology reports 2016; 17:18.","journal-title":"Current urology reports"},{"key":"2006_CR3","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.2967\/jnumed.115.154336","volume":"56","author":"SP Rowe","year":"2015","unstructured":"Rowe SP, Gage KL, Faraj SF, et al. (1) (8) F-DCFBC PET\/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer. J Nucl Med 2015; 56:1003\u20131010.","journal-title":"J Nucl Med"},{"key":"2006_CR4","doi-asserted-by":"crossref","unstructured":"Kosuri S, Akhtar NH, Smith M, et al. Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy. Adv Urol 2012; 2012.","DOI":"10.1155\/2012\/921674"},{"key":"2006_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/ajco.12256","volume":"10","author":"HH Yao","year":"2014","unstructured":"Yao HH, Hong M, Corcoran NM, et al. Advances in local and ablative treatment of oligometastasis in prostate cancer. Asia Pac J Clin Oncol 2014; 10:308\u2013321.","journal-title":"Asia Pac J Clin Oncol"},{"key":"2006_CR6","doi-asserted-by":"crossref","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, et al. European Association of Urology. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2014; 65:467\u2013479.","DOI":"10.1016\/j.eururo.2013.11.002"},{"key":"2006_CR7","doi-asserted-by":"crossref","unstructured":"Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur urol 2017; 71:618\u2013629.","DOI":"10.1016\/j.eururo.2016.08.003"},{"key":"2006_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","volume":"65","author":"A Heidenreich","year":"2014","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, et al. EAU guidelines on prostate cancer: Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 2014; 65:124\u2013137.","journal-title":"Eur Urol"},{"key":"2006_CR9","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.eururo.2011.11.008","volume":"61","author":"A Briganti","year":"2012","unstructured":"Briganti A, Abdollah F, Nini A, et al. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection. Eur Urol 2012; 61:1132\u20131138.","journal-title":"Eur Urol"},{"key":"2006_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.eururo.2011.01.015","volume":"60","author":"T Budiharto","year":"2011","unstructured":"Budiharto T, Joniau S, Lerut E, et al. Prospective evaluation of C-11-choline positron emission tomography\/computed tomography and diffusion weighted magnetic resonance imaging for the nodal staging of prostate cancer with high risk lymph node metastases. Eur Urol 2011; 60:125\u2013130.","journal-title":"Eur Urol"},{"key":"2006_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cpet.2016.08.004","volume":"12","author":"F Ceci","year":"2017","unstructured":"Ceci F, Fiorentino M, Castellucci P, Fanti S. Molecular Imaging and Precision Medicine in Prostate Cancer. PET Clin 2017; 12:83\u201392.","journal-title":"PET Clin"},{"key":"2006_CR12","doi-asserted-by":"crossref","unstructured":"Lopci E, Chiti A, Lazzeri M. Re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for 18F\/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Eur Urol 2016; 70: e112\u2013e113.","DOI":"10.1016\/j.eururo.2016.03.025"},{"key":"2006_CR13","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.juro.2016.02.3000","volume":"196","author":"H Rhee","year":"2016","unstructured":"Rhee H, Thomas P, Shepherd B, et al. Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer. J Urol 2016; 196:1261\u20131267.","journal-title":"J Urol"},{"key":"2006_CR14","doi-asserted-by":"crossref","unstructured":"Buyyounouski MK, Choyke PL, McKenney JK, et al. Prostate cancer\u2013major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA: a cancer journal for clinicians 2017; 67:245-53.","DOI":"10.3322\/caac.21391"},{"key":"2006_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.acra.2018.05.020","volume":"26","author":"MA Hamed","year":"2019","unstructured":"Hamed MA, Basha MA, Ahmed H, Obaya AA, Afifi AH, Abdelbary EH. 68Ga-PSMA PET\/CT in Patients with Rising Prostatic-Specific Antigen After Definitive Treatment of Prostate Cancer: Detection Efficacy and Diagnostic accuracy. \u200bAcad Radiol\u00a02019; 26:450\u2013460.","journal-title":"Acad Radiol"},{"key":"2006_CR16","first-page":"110","volume":"32","author":"KG Kallur","year":"2017","unstructured":"Kallur KG, Ramachandra PG, Rajkumar K, et al. Clinical utility of gallium-68 PSMA PET\/CT scan for prostate cancer. Indian journal of nuclear medicine: IJNM: the official journal of the Society of Nuclear Medicine, India 2017; 32:110\u2013117.","journal-title":"Indian journal of nuclear medicine: IJNM: the official journal of the Society of Nuclear Medicine, India"},{"key":"2006_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2967\/jnumed.115.169243","volume":"57","author":"K Rahbar","year":"2016","unstructured":"Rahbar K, Weckesser M, Huss S, et al. Correlation of intraprostatic tumor extent with 68\u00a0Ga-PSMA distribution in patients with prostate cancer. Journal of Nuclear Medicine 2016; 57:563\u2013567.","journal-title":"Journal of Nuclear Medicine"},{"key":"2006_CR18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/MNM.0000000000000290","volume":"36","author":"L Kabasakal","year":"2015","unstructured":"Kabasakal L, Demirci E, Ocak M, et al. Evaluation of PSMA PET\/CT imaging using a 68\u00a0Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging. Nuclear medicine communications 2015; 36:582\u2013587.","journal-title":"Nuclear medicine communications"},{"key":"2006_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.eururo.2015.06.010","volume":"69","author":"L Bud\u00e4us","year":"2016","unstructured":"Bud\u00e4us L, Leyh-Bannurah SR, Salomon G, et al. Initial experience of 68Ga-PSMA PET\/CT imaging in high-risk prostate cancer patients prior to radical prostatectomy. Euro urolo 2016; 69:393\u2013396.","journal-title":"Euro urolo"},{"key":"2006_CR20","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00259-017-3699-z","volume":"44","author":"M McCarthy","year":"2017","unstructured":"McCarthy M, Langton T, Kumar D, Campbell A. Comparison of PSMAHBED and PSMA-I&T as diagnostic agents in prostate cancer. Eur J Nucl Med Mol Imaging 2017; 44:1455\u20131462.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2006_CR21","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1097\/RLU.0000000000001349","volume":"41","author":"C Sachpekidis","year":"2016","unstructured":"Sachpekidis C, Kopka K, Eder M, et al. 68Ga-PSMA-11 dynamic PET\/CT imaging in primary prostate cancer. Clin Nucl Med 2016; 41:e473\u2013479.","journal-title":"Clin Nucl Med"},{"key":"2006_CR22","doi-asserted-by":"crossref","unstructured":"Berger I, Annabattula C, Lewis J, et al. 68\u00a0Ga-PSMA PET\/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology. Prostate cancer and prostatic diseases 2018; 21:204\u2013211.","DOI":"10.1038\/s41391-018-0048-7"},{"key":"2006_CR23","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","volume":"70","author":"M Perera","year":"2016","unstructured":"Perera M, Papa N, Christidis D, et al. Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis. Eur Urol 2016; 70:926\u2013937","journal-title":"Eur Urol"},{"key":"2006_CR24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/1754-9485.12791","volume":"62","author":"HS Wong","year":"2018","unstructured":"Wong HS, Leung J, Bartholomeusz D, et al. Comparative study between 68Ga\u2010prostate\u2010specific membrane antigen positron emission tomography and conventional imaging in the initial staging of prostate cancer. Journal of medical imaging and radiation oncology 2018; 62:816-822.","journal-title":"Journal of medical imaging and radiation oncology"},{"key":"2006_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13014-016-0646-2","volume":"11","author":"S Dewes","year":"2016","unstructured":"Dewes S, Schiller K, Sauter K et al. Integration of (68) Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study. Radiat Oncol 2016; 11:73.","journal-title":"Radiat Oncol"},{"key":"2006_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/ajco.12872","volume":"14","author":"G Hruby","year":"2018","unstructured":"Hruby G, Eade T, Emmett L, et al. 68Ga-PSMA-PET\/CT staging prior to definitive radiation treatment for prostate cancer. Asia-Pacific J of Clin Oncol 2018; 14: 343\u2013346.","journal-title":"Asia-Pacific J of Clin Oncol"},{"key":"2006_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.eururo.2018.03.030","volume":"47","author":"S Han","year":"2018","unstructured":"Han S, Woo S, Kim YJ, Suh CH. Impact of 68Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis. European urology 2018; 47:179\u2013190.","journal-title":"European urology"},{"key":"2006_CR28","first-page":"291","volume":"7","author":"V Schreiter","year":"2016","unstructured":"Schreiter V, Gericke M, Beck M, Ghadjar P, Boening G, Schreiter NF. Usefulness of Ga-68 HBED-CC PSMA PET\/CT for Tumor Staging in the Initial Diagnostic Assessment of Prostate Cancer. J Nucl Med Radiat Ther 2016; 7: 291.","journal-title":"J Nucl Med Radiat Ther"},{"key":"2006_CR29","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/MNM.0000000000000738","volume":"38","author":"DP Meyrick","year":"2017","unstructured":"Meyrick DP, Asokendaran M, Skelly LA, Lenzo NP, Henderson A. The role of 68\u00a0Ga-PSMA-I&T PET\/CT in the pretreatment staging of primary prostate cancer. Nuclear medicine communications 2017; 38:956\u2013963.","journal-title":"Nuclear medicine communications"},{"key":"2006_CR30","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2967\/jnumed.117.190827","volume":"58","author":"WP Fendler","year":"2017","unstructured":"Fendler WP, Calais J, Allen-Auerbach M, et al. 68Ga-PSMA-11 PET\/CT interobserver agreement for prostate cancer assessments: an international multicenter prospective study. Journal of Nuclear Medicine 2017; 58:1617\u20131623.","journal-title":"Journal of Nuclear Medicine"},{"key":"2006_CR31","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","volume":"195","author":"T Maurer","year":"2016","unstructured":"Maurer T, Gschwend JE, Rauscher I, et al. Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer. J Urol 2016; 195:1436\u20131443.","journal-title":"J Urol"},{"key":"2006_CR32","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00259-017-3631-6","volume":"44","author":"C Uprimny","year":"2017","unstructured":"Uprimny C, Kroiss AS, Decristoforo C, et al. 68Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour. Eur J Nucl Med Mol Imaging 2017; 44:941\u2013949.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2006_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00259-017-3850-x","volume":"45","author":"B Kranzb\u00fchler","year":"2018","unstructured":"Kranzb\u00fchler B, Nagel H, Becker AS, et al. Clinical performance of 68Ga-PSMA-11 PET\/MRI for the detection of recurrent prostate cancer following radical prostatectomy. Eur J Nucl Med Mol Imaging 2018; 45:20\u201330.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2006_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00259-017-3852-8","volume":"45","author":"M Sathekge","year":"2018","unstructured":"Sathekge M, Lengana T, Maes A, et al. 68Ga-PSMA-11 PET\/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans.\u00a0Eur J Nucl Med Mol Imaging 2018; 45:226\u2013234.\u200f","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-019-02006-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-019-02006-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-019-02006-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T23:17:02Z","timestamp":1586215022000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-019-02006-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2006"],"URL":"https:\/\/doi.org\/10.1007\/s00261-019-02006-2","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"8 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this manuscript declare no relevant conflicts of interest, and no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional review board approval was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}